<SEC-DOCUMENT>0001104659-22-094045.txt : 20220926
<SEC-HEADER>0001104659-22-094045.hdr.sgml : 20220926
<ACCEPTANCE-DATETIME>20220824163030
<PRIVATE-TO-PUBLIC>
ACCESSION NUMBER:		0001104659-22-094045
CONFORMED SUBMISSION TYPE:	CORRESP
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20220824

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Evaxion Biotech A/S
		CENTRAL INDEX KEY:			0001828253
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			G7
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		CORRESP

	BUSINESS ADDRESS:	
		STREET 1:		BREDGADE 34E
		CITY:			COPENHAGEN K
		STATE:			G7
		ZIP:			1260
		BUSINESS PHONE:		4531262615

	MAIL ADDRESS:	
		STREET 1:		BREDGADE 34E
		CITY:			COPENHAGEN K
		STATE:			G7
		ZIP:			1260
</SEC-HEADER>
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="tm2220308d3_correspimg001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Evaxion Biotech A/S <BR>
Dr. Neergaards Vej 5F, 2970<BR>
H&oslash;rsholm, Denmark</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-right: 3in; margin-bottom: 0pt">August 24, 2022</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">U.S. Securities and Exchange Commission</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Office of Life Sciences</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Division of Corporation Finance</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">100 F Street, N.E.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Washington, D.C. 20549</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; font-size: 10pt">Attn:</TD>
    <TD STYLE="font-size: 10pt">Tim Buchmiller</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Re: Evaxion Biotech A/S &ndash; Registration Statement on Form F-1 Filed on July 7, 2022, as amended (File No. 333-266050)</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 4.5pt 0pt 3pt; text-indent: 0.25in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Acceleration Request </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Requested Date:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;August 26, 2022</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Requested Time:&nbsp;&nbsp;&nbsp;&nbsp;4:30 P.M. Eastern Time</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dear Mr. Buchmiller:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In accordance with Rule 461 of Regulation C of
the General Rules and Regulations under the Securities Act of 1933, as amended, the undersigned registrant (the &ldquo;<B><I>Registrant</I></B>&rdquo;)
hereby requests that the Securities and Exchange Commission (the &ldquo;<B><I>Commission</I></B>&rdquo;) take appropriate action to cause
the above-referenced Registration Statement on Form F-1 filed on July 7, 2022, as amended (File No. 333-266050) (the &ldquo;<B><I>Registration
Statement</I></B>&rdquo;), to become effective on Friday, August 26, 2022, at 4:30 p.m., Eastern Time, or as soon thereafter as practicable,
or at such later time as the Registrant or its counsel, Duane Morris LLP, may orally request via telephone call to the staff (the &ldquo;<B><I>Staff</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Once the Registration Statement has been declared effective, please orally confirm that event with Dwight A. Kinsey of Duane Morris LLP
by telephone at (917) 620-3675, or in his absence you can also contact Rina R. Patel of Duane Morris LLP by telephone at (212) 404-8736,
or if you have any questions or require additional information regarding this matter. Thank you for your assistance and cooperation in
this matter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Registrant understands that the Staff will consider this request as confirmation by the Registrant of its awareness of its responsibilities
under the federal securities laws as they relate to the offering of the securities covered by the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" BORDER="0" STYLE="width: 100%; margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: top">
  <TD STYLE="padding-left: 10pt; text-indent: -10pt">&nbsp;</TD>
  <TD COLSPAN="2" STYLE="padding-left: 10pt; text-indent: -10pt">Very truly yours,</TD></TR>
<TR STYLE="vertical-align: top">
  <TD STYLE="padding-left: 10pt; text-indent: -10pt">&nbsp;</TD>
  <TD COLSPAN="2" STYLE="padding-left: 10pt; text-indent: -10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
  <TD STYLE="padding-left: 10pt; text-indent: -10pt">&nbsp;</TD>
  <TD COLSPAN="2" STYLE="padding-left: 10pt; text-indent: -10pt">Evaxion Biotech A/S</TD></TR>
<TR STYLE="vertical-align: top">
  <TD STYLE="padding-left: 10pt; text-indent: -10pt">&nbsp;</TD>
  <TD COLSPAN="2" STYLE="padding-left: 10pt; text-indent: -10pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
  <TD STYLE="padding-left: 10pt; text-indent: -10pt; width: 50%">&nbsp;</TD>
  <TD STYLE="padding-left: 10pt; text-indent: -10pt; width: 3%">By:</TD>
  <TD STYLE="border-bottom: Black 1pt solid; padding-left: 10pt; text-indent: -10pt">/s/ Lori Hollander</TD></TR>
<TR STYLE="vertical-align: top">
  <TD STYLE="padding-left: 10pt; text-indent: -10pt">&nbsp;</TD>
  <TD STYLE="padding-left: 10pt; text-indent: -10pt">&nbsp;</TD>
  <TD STYLE="padding-left: 10pt; text-indent: -10pt">Lori Hollander</TD></TR>
<TR STYLE="vertical-align: top">
  <TD STYLE="padding-left: 10pt; text-indent: -10pt">&nbsp;</TD>
  <TD STYLE="padding-left: 10pt; text-indent: -10pt">&nbsp;</TD>
  <TD STYLE="padding-left: 10pt; text-indent: -10pt">Vice President,
Financial Planning and Analysis</TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 2.5in; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; font-size: 10pt">cc:</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Lars Wegner, Evaxion Biotech A/S</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Jesper Nyegaard Nissen, Evaxion Biotech A/S</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Bo Karmark, Evaxion Biotech A/S</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dwight A. Kinsey, Duane Morris LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Rina R. Patel, Duane Morris LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Lars L&uuml;thjohan Jensen, Mazanti-Andersen<BR>
Gyrithe Falck, Mazanti-Andersen</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection Last; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>tm2220308d3_correspimg001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm2220308d3_correspimg001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !A 6(# 2(  A$! Q$!_\0
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MM& 445B:1XKTK7-7U32[*5VNM,E\J<,A ST.#W ((^H],$E@-NBBBD 4444
M%%%% !1110 4444 %%%% !1110 4444 %<G\3?\ DF^N?]</_9A765R?Q-_Y
M)OKG_7#_ -F%5'XD)[&+\-_%OARV\ :3:W.N:=;3PQE)(I[E(V4[CV8@]^M=
M8GC#PQ+(L<?B/2'=B%55OHR23T &ZN/^'/@OPU=> M+N[K1+*XN+B,R22SQ"
M1B<D=3G XZ"NK3P/X5C=73P[I:LIR"+5.#^55+EN]Q*]C?KS3XO^%Y=0T>'Q
M'IH*:II!$H=/O&(')_%3\P_'UKTND90RE6 *D8(/>IC+E=QM71SW@CQ1#XN\
M+VVI(5$^/+N8U/W)1U'T/4>Q%;=[>0:?8SWEU(L=O ADD=NBJ!DFO&M.<_"K
MXI2Z=*Q3P]K)#0L3\L9)X^FTG:?]D@FNE\;7;^+?$5CX&T^7,#XNM5FC;_5P
MJ<A/J3C\U[9JG#WM-A)Z$OP^LY]=U._\=:E$R37^8=/B?K#;*>./5B/Z]Z]"
MJ.""*UMXK>"-8X8E"(BC 50, "N=\>^*H_"'A6YU#*FZ;]U:H?XI#TX]!R3]
M*EWE+0>R//OB%>77CWQS9^!M*F*6ULWF7LP&0K <Y'?:#CKRS8[5J^$8)?AS
MXP/A&ZN7GTK5%,^FSR#&)1]Y#VR>/T_O5S'PR\1Z-X5L;N]U2VU:;6+^0M-*
MMHS@)G(&>Y)RQ/N/2M;QUXTT'Q1X>:"VM=8BU*V<7%C-]B8%)5Y'/8'I^1[5
MLT_@Z?UJ3YGL=%<WX&\4)XL\,6]^0$NT_<W<70I*O7CMGJ/8UTE8-6=F6>5_
M&#2'1;3785RJ?Z/<$=AG*'\R1^(KF/#WBZ_L?#]WI<)Q'.X*R9YC!X8#Z\?3
MFO2/B1K^G:7X;GT^Z19[B_C,<4!_]#/H <$>^/P\3BN([2 R/PJC@?TKT<.N
M>G:2V.&L^6I>+/6?A]I37%PVHR+^ZA^6/(^\Y']!_,5Z-6!X)N[2^\':9<6:
M!(VA 91V<</_ ./ UOUQ5IN4W<ZJ45&"L>3^._\ DLW@O\/_ $,UZQ7D_CO_
M )+-X+_#_P!#->L5,]HEK=GFGQ3\1:BEQIGA'0Y?+U'5V"R2 X,<1.WKU&3G
M)[!376>%/!^D^$=,2UT^!?-VCSKEA^\E/J3Z>W05Y_X_<:!\8/"_B*[XT]T%
MNTC=(R"P))[ "0'\#7KX((!!R#3EI%)"6["N6\:>!].\8::RR(L&HQC-M>(,
M/&PZ GNOM^6#74TR66."%YI75(T4L[,<!0.234)M.Z*. ^%'BF]UK2KS2-79
MFU72)?)E=N6=<D D]R"K _0'O7H5>1?!\-J7BCQAK\*G[#=WA\ER,;B7=\?@
M&7\Q7KM5424M!1V/F?X8^%_$>H+>:_X>U..TN;)@B1/DBX.,E&[;<8ZYY],9
MKVSPCXXM_$3RZ;>P-IVO6O%S82\'(ZLF?O+_ "^F">.^ '_(M:K_ -?@_P#0
M!7:^+O!5IXF6*[AF>PUFVYM;^'AT/8-CJOM6E62<VF3%::'45Y%\,/\ DIWC
MS_K\D_\ 1TE;WA[QW/97Q\/^-5BT[5HE_=W3';!=J!]Y6X /MT^AXKF_A+=0
M7WQ"\:W=M()()[AI8W'1E:5R#^1J5%J,KC;NT>QT445D4%%%% !1110 4444
M %%%% !1110 4444 %%%% !7.>/=/NM4\#:M8V,+37,T.V.->K'<*Z.BFG9W
M \E\*ZWXX\-^&[/2)/ 4UU]E4HLJWBQY&21D8;GGUK9_X3?QI_T3>Y_\&2?_
M !%>@T53FGK85O,R?#VI:CJNF?:-4T:32;C>5^SO,LO Z-D8_4"M:BBH8SC_
M (D^$1XN\*300H#?VV9K0]RP'*?\"''UP>U4/A-X//A?PLMQ=1;=2U#$LP(Y
MC7^!/; .3[D^E=_15<[Y>45E>X5YGXH\&ZQXN^)FGMJ,*?\ ",6,0D7#@B1N
MK*5ZY) ![;1UR<5Z911&3CJ@:N     P!1114C.(AT#4M"^)C:EI5OYFC:Q&
M?[00. ()E!(DP>N[IQW+>U;GBOQ-9^$]"FU*[(8CY880<&5ST4?S)[ &MF61
M(8GEE<)&BEF9C@ #J37RQX^\:3>,_$SRQ,W]G6Y,=G'@C*YY8CU;K],#M711
MINK+79&56?LXZ;A/J.J>+?$+7$P>YOKIPJ1H.GHJCL!72?$3P)+X8\*:7J'F
MF242F.\"G*JS#*X]A@C/?->@?"_P"/#M@NJZE$/[5N%RJ,/^/=#V_P!X]_3I
MZYV_B3IZ:E\.];B<9\NV:<>QC^?_ -EK>6)M448;(PA0]QRENSD?@1JANO#V
MI6#.6-M<+( >RNO^*&O6*\/_ &>HWW>()<$1XMU!QP3^\_E_6O<*Y\2E[5V-
MZ/\ #1P'BKPMJFJ?$KPQK%K$C65EG[0Y< I@D].^<X&/TKOZI7VJVNG7%E#<
M,0]Y-Y,6!GYL$\^@X SZL!WI7U*&/6(-+*R&>:!YU( V[495;)SURZ_G63;:
M1H5/$GAO3_%6BRZ7J49:)^5=>&C8=&4]B/\ ZU<3I[>.O D:V,MA_P )-HT7
M$,UNVVXB0#@%3RWL.>G7H*]#U*_ATO3+K4+@,8+6%YI-@R=J@DX'T%1SZSIU
MFL'VV]M[1IUW1I/*J,>GJ><9'2A2=K= :.//Q0RF%\&>*S-TV?V?QGZ[L_I6
M;J%AXX^(0^QWMNOAO0&(\V,R"2XG7T..@]CCWW5Z&VLZ8MA]O;4;06>[9]H\
MY?+W9VXW9QG/'UI;;5M.O1)]EO[6?RU#OY<RML4]"<'@<&GS6U2"W<9HVC6.
M@:5!ING0"&VA&%4=2>Y)[D]S5^J<>JZ=+;R7$=];/#'$LSR+*I548;@Q.> 1
MSGTYHM]6TZ[LY+NWO[66VBSYDR2J43 R<G.!P0>>U3J,XGX1^%-5\*:'J%OJ
MT*12RW99%5PV5  SQV..*]"K.N=;M(+"*]B<74$ES%;!X&5@&DD6,$\]F89[
MU9>_LX[Q;-[N!;IP"L)D <CG&%Z_PG\CZ4Y-R=V)::&;XF\+:7XMTIK#4X=R
M]8Y5X>)O[RG_ "#WKB/AGX'U+P5XGUJ"[Q+:RPQFWN5&%D 8Y&.Q&>17HW]J
MZ=]N^P_;K;[7R/(\U=_ R?ESGIS^-/M[^SO-OV:[@GW)O7RI V5SC(P>F01G
MVH4FER] LKW+%%%%2,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** /*OC?XJ;2O#\6AVLFVYU'/FX/*PCK_P!]
M'CZ!JY;X+^ QJ-R/$VI1 VL#XLXV'$D@/+_13T]_ISD>)(;GXB_&2?3K=F\E
M9_LP<#B.*/AV_,,1[D#O7T;86-MIFGV]C:1"*W@01QH.P KKE+V5)06[W,%'
MGGS/9%BL?Q8\<?@[6WF3?$MA.77^\/+;(K8J"\LX-0LY;2ZC$D$J[9$/1E[@
M^QZ&N5;F[.%^#GA^30_ L4UPA6?4)#<E6'*J0 @_(9_X%7H-(      .@%+3
ME)R;;$E961B:QX?.L22N]T8SY(2W*H<PN'#[_O88Y5#@C^ 59;2V?7[756G&
M^"UDMC&(^&WLC$YSQS&..>IK2HI7&<M;?#_0=+T35]-T:U-@NJ6Y@G<2/*<;
M64$!V/(#M5O6_#;:W8_99+L1 V4MH[+%DGS H+#YN/N].>M;U%',]Q6,.Z\/
M-=Z=<6CW2@2WL=V&6+ILD20+C//* 9]#3M-T$V$Y=KA'1HY$*K%LY>5I"<Y/
M]XC]:VJ*+L9S>F^%GL-)N-/-^)8Y+&.Q1O)P41%9%)^;DX;GISZ=*G'AP&PO
MK1[KY;H1898\%&1%4'J<CY <?45NT478&++H!FT^2!KH":6]BO9)!%A2\<B.
M %SP/W:CJ>].FT%9M6:\,_[MY8IGB*9.^,$+AL\#ID8[>YK8HHNP.:L-)O[?
MQ==W\D49MIF<J2V1&"J ;/FX)*9;*]3][M5W0]).G3ZC.R[/M$Y:*/.?+CR3
MC\7:1_;?CM6Q11< HHHI %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %-=MD;/C.T$XIU% 'CGP)T<R6^J^)+D;KBY
MF,".0,X&&<CZDC_OFO8ZYKP+HC>'?#ATIDV""ZG">Z&1BAS[J5KI:NI+FDV3
M%65@HHHJ"@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
/"BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
